Pawel Wiczling
Title
Cited by
Cited by
Year
Prediction of peptide retention at different HPLC conditions from multiple linear regression models
T Ba̧czek, P Wiczling, M Marszałł, YV Heyden, R Kaliszan
Journal of Proteome Research 4 (2), 555-563, 2005
1062005
Simultaneous Determination of pKa and Lipophilicity by Gradient RP HPLC
P Wiczling, P Kawczak, A Nasal, R Kaliszan
Analytical chemistry 78 (1), 239-249, 2006
1002006
Determination of pKa by pH Gradient Reversed-Phase HPLC
P Wiczling, MJ Markuszewski, R Kaliszan
Analytical Chemistry 76 (11), 3069-3077, 2004
1002004
pH gradient reversed-phase HPLC
R Kaliszan, P Wiczling, MJ Markuszewski
Analytical chemistry 76 (3), 749-760, 2004
682004
Gradient HPLC in the determination of drug lipophilicity and acidity
R Kaliszan, P Haber, T Baczek, D Siluk
Pure and Applied Chemistry 73 (9), 1465-1475, 2001
652001
pH gradient high-performance liquid chromatography: theory and applications
R Kaliszan, P Wiczling, MJ Markuszewski
Journal of Chromatography A 1060 (1-2), 165-175, 2004
522004
pH/organic solvent double-gradient reversed-phase HPLC
P Wiczling, MJ Markuszewski, M Kaliszan, R Kaliszan
Analytical chemistry 77 (2), 449-458, 2005
492005
Reversed-phase TLC and HPLC retention data in correlation studies with in silico molecular descriptors and druglikeness properties of newly synthesized anticonvulsant …
N Perisic-Janjic, R Kaliszan, P Wiczling, N Milosevic, G Uscumlic, ...
Molecular pharmaceutics 8 (2), 555-563, 2011
472011
Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics
A Bienert, P Wiczling, E Grzśkowiak, JB Cywiński, K Kusza
Pharmacological reports 64 (4), 782-795, 2012
442012
Population modeling of filgrastim PK‐PD in healthy adults following intravenous and subcutaneous administrations
W Krzyzanski, P Wiczling, P Lowe, E Pigeolet, M Fink, A Berghout, ...
The Journal of Clinical Pharmacology 50 (S9), 101S-112S, 2010
442010
Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti‐CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitus
P Wiczling, M Rosenzweig, L Vaickus, WJ Jusko
The Journal of Clinical Pharmacology 50 (5), 494-506, 2010
422010
Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery
P Wiczling, A Bienert, P Sobczyński, R Hartmann-Sobczyńska, K Bieda, ...
Pharmacological Reports 64 (1), 113-122, 2012
352012
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes
G Hale, P Rebello, I Al Bakir, E Bolam, P Wiczling, WJ Jusko, ...
The Journal of Clinical Pharmacology 50 (11), 1238-1248, 2010
332010
The application of gradient reversed-phase high-performance liquid chromatography to the pKa and logkw determination of polyprotic analytes
P Wiczling, M Waszczuk-Jankowska, MJ Markuszewski, R Kaliszan
Journal of Chromatography A 1214 (1-2), 109-114, 2008
322008
pH gradient as a tool for the separation of ionizable analytes in reversed-phase high-performance chromatography
P Wiczling, R Kaliszan
Analytical chemistry 82 (9), 3692-3698, 2010
312010
Verification of the exponential model of body temperature decrease after death in pigs
M Kaliszan, R Hauser, R Kaliszan, P Wiczling, J Buczyński, M Penkowski
Experimental Physiology 90 (5), 727-738, 2005
312005
The simultaneous determination of hydrophobicity and dissociation constant by liquid chromatography–mass spectrometry
P Wiczling, W Struck-Lewicka, D Siluk, MJ Markuszewski, R Kaliszan
Journal of Pharmaceutical and Biomedical Analysis 94, 180-187, 2014
272014
Population pharmacokinetic modelling of filgrastim in healthy adults following intravenous and subcutaneous administrations
P Wiczling, P Lowe, E Pigeolet, F Lüdicke, S Balser, W Krzyzanski
Clinical pharmacokinetics 48 (12), 817-826, 2009
272009
Least absolute shrinkage and selection operator and dimensionality reduction techniques in quantitative structure retention relationship modeling of retention in hydrophilic …
E Daghir-Wojtkowiak, P Wiczling, S Bocian, Ł Kubik, P Kośliński, ...
Journal of Chromatography A 1403, 54-62, 2015
262015
Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients
A Bienert, K Kusza, K Wawrzyniak, E Grześkowiak, ZJ Kokot, J Matysiak, ...
Journal of pharmacokinetics and pharmacodynamics 37 (3), 289-304, 2010
262010
The system can't perform the operation now. Try again later.
Articles 1–20